GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (FRA:NOVA) » Definitions » 6-1 Month Momentum %
中文

Novo Nordisk A/S (FRA:NOVA) 6-1 Month Momentum % : 31.35% (As of Apr. 24, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Novo Nordisk A/S 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-24), Novo Nordisk A/S's 6-1 Month Momentum % is 31.35%.

The industry rank for Novo Nordisk A/S's 6-1 Month Momentum % or its related term are showing as below:

FRA:NOVA's 6-1 Month Momentum % is ranked better than
70.86% of 1520 companies
in the Biotechnology industry
Industry Median: 2.99 vs FRA:NOVA: 31.35

Competitive Comparison of Novo Nordisk A/S's 6-1 Month Momentum %

For the Biotechnology subindustry, Novo Nordisk A/S's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk A/S's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's 6-1 Month Momentum % falls into.



Novo Nordisk A/S  (FRA:NOVA) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novo Nordisk A/S  (FRA:NOVA) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Novo Nordisk A/S 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (FRA:NOVA) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (FRA:NOVA) Headlines